# Digoxin Short Term Treatment Assessment Randomized Trial in AHF

> **NCT02544815** · PHASE3 · UNKNOWN · sponsor: **University of Monastir** · enrollment: 500 (estimated)

## Conditions studied

- Acute Heart Failure

## Interventions

- **DRUG:** Digoxin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02544815
- **Lead sponsor:** University of Monastir
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-01
- **Primary completion:** 2025-07-31
- **Final completion:** 2025-07-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2023-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02544815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02544815, "Digoxin Short Term Treatment Assessment Randomized Trial in AHF". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02544815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*